Rankings
▼
Calendar
XOMAP
XOMA Corporation
$309M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
-$10M
-243.5% margin
Operating Income
-$14M
-353.1% margin
Net Income
-$8M
-211.1% margin
EPS (Diluted)
$-0.74
QoQ Revenue Growth
-91.8%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$53M
Total Liabilities
$60M
Stockholders' Equity
-$8M
Cash & Equivalents
$46M
← FY 2016
All Quarters
Q2 2016 →
XOMAP Q1 2016 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena